Scitech appointed authorised distributor for GreatEyes and BaySpec

SciTech Pty Ltd

Wednesday, 01 March, 2017

Scitech appointed authorised distributor for GreatEyes and BaySpec

Instrumentation supplier Scitech has been appointed the authorised distributor in Australia and New Zealand for both German-based imaging company GreatEyes and US-based spectral sensing company BaySpec.

GreatEyes develops, manufactures and markets a huge portfolio of high-performance scientific imaging and spectroscopy cameras. A combination of highly sensitive sensors with ultralow-noise electronics allows for optimal detection of weak signals which can be used in the NIR, VIS, UV, EUV and X-ray range.

The company’s products are suitable for imaging and spectroscopy applications including soft X-ray spectroscopy, plasma emission spectroscopy, fluorescence in vivo imaging, low-energy electron diffraction (LEED) imaging, thickness determination of ultrathin foils in the EUV spectrum, XUV spectroscopy and soft X-ray single shot NEXAFS spectroscopy. GreatEyes also manufactures electroluminescence and photoluminescence inspection systems for solar cells, wafers and solar modules in the solar industry.

BaySpec, meanwhile, is a designer, manufacturer and marketer of spectral instruments, including UV-VIS-NIR-SWIR spectrometers, benchtop and portable NIR/SWIR and Raman analysers, confocal Raman microscopes, hyperspectral imagers, mass spectrometers, and OEM spectral engines and components for R&D, pharmaceuticals, chemical, semiconductor and the optical telecommunications industries.

Unlike most optical device companies today, BaySpec manufactures every major component of its systems in-house in the USA. From packaging the detectors, to creating the gratings, to the control electronics and operating software, it is all done in their Silicon Valley headquarters.

Related News

Dr Chris Baldwin is new HaemaLogiX CEO and Managing Director

Having commenced in January, Dr Chris Baldwin is clinical stage Australian biotechnology company...

Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO

To lead the commercialisation of Vaxxas's proprietary high‑density microarray patch (HD‑MAP)...

Optics11 Life appoints Jacquelien ten Dam as CEO

Optics11 Life plans to accelerate its commercial growth in key markets while building strategic...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd